Literature DB >> 11509644

Plasmid vaccination with insulin B chain prevents autoimmune diabetes in nonobese diabetic mice.

A Bot1, D Smith, S Bot, A Hughes, T Wolfe, L Wang, C Woods, M von Herrath.   

Abstract

The insulin B (InsB) chain bears major type 1 diabetes-associated epitopes of significance for disease in humans and nonobese diabetic (NOD) mice. Somatic expression of InsB chain initiated early in life by plasmid inoculation resulted in substantial protection of female NOD mice against disease. This was associated with a T2 shift in spleen, expansion of IL-4-producing and, to a lesser extent, of IFN-gamma-secreting T cells in pancreatic lymph nodes, as well as intermolecular Th2 epitope spreading to glutamic acid decarboxylase determinants. A critical role of IL-4 for the Ag-specific protective effect triggered by plasmid administration was revealed in female IL-4(-/-) NOD mice that developed diabetes and higher Th1 responses. Coadministration of IL-4-expressing plasmid or extension of the vaccination schedule corrected the unfavorable response of male NOD mice to DNA vaccination with InsB chain. Thus, plasmid-mediated expression of the InsB chain early in diabetes-prone mice has the potential to prevent transition to full-blown disease depending on the presence of IL-4.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11509644     DOI: 10.4049/jimmunol.167.5.2950

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  DNA vaccination encoding glutamic acid decarboxylase can enhance insulitis and diabetes in correlation with a specific Th2/3 CD4 T cell response in non-obese diabetic mice.

Authors:  A Gauvrit; M Debailleul; A-T Vu; P Sai; J-M Bach
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

Review 2.  Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes.

Authors:  Mark C Johnson; Bo Wang; Roland Tisch
Journal:  Hum Vaccin       Date:  2011-01-01

3.  Expression of cholera toxin B subunit and the B chain of human insulin as a fusion protein in transgenic tobacco plants.

Authors:  Dora Li; Jennifer O'Leary; Yan Huang; Norman P A Huner; Anthony M Jevnikar; Shengwu Ma
Journal:  Plant Cell Rep       Date:  2005-12-02       Impact factor: 4.570

4.  Regulatory cytokine production stimulated by DNA vaccination against an altered form of glutamic acid decarboxylase 65 in nonobese diabetic mice.

Authors:  Yelena Glinka; Renée De Pooter; France Croze; Gérald J Prud'homme
Journal:  J Mol Med (Berl)       Date:  2003-02-11       Impact factor: 4.599

5.  Inducing immune tolerance: a focus on Type 1 diabetes mellitus.

Authors:  Dan Xu; Suchitra Prasad; Stephen D Miller
Journal:  Diabetes Manag (Lond)       Date:  2013-09-01

6.  MAS-1 adjuvant immunotherapy generates robust Th2 type and regulatory immune responses providing long-term protection from diabetes in late-stage pre-diabetic NOD mice.

Authors:  Li Zhang; Pilar Londono; Liping Yu; Stephen Grimes; Peter Blackburn; Peter Gottlieb; George S Eisenbarth
Journal:  Autoimmunity       Date:  2014-05-01       Impact factor: 2.815

Review 7.  Clinical optimization of antigen specific modulation of type 1 diabetes with the plasmid DNA platform.

Authors:  Peter Gottlieb; Paul J Utz; William Robinson; Lawrence Steinman
Journal:  Clin Immunol       Date:  2013-09-01       Impact factor: 3.969

Review 8.  Type 1 diabetes: translating mechanistic observations into effective clinical outcomes.

Authors:  Kevan C Herold; Dario A A Vignali; Anne Cooke; Jeffrey A Bluestone
Journal:  Nat Rev Immunol       Date:  2013-04       Impact factor: 53.106

Review 9.  Can we learn from viruses how to prevent type 1 diabetes?: the role of viral infections in the pathogenesis of type 1 diabetes and the development of novel combination therapies.

Authors:  Matthias von Herrath
Journal:  Diabetes       Date:  2009-01       Impact factor: 9.461

10.  Key role of the GITR/GITRLigand pathway in the development of murine autoimmune diabetes: a potential therapeutic target.

Authors:  Sylvaine You; Lynn Poulton; Steve Cobbold; Chih-Pin Liu; Michael Rosenzweig; Douglas Ringler; Wen-Hui Lee; Berta Segovia; Jean-François Bach; Herman Waldmann; Lucienne Chatenoud
Journal:  PLoS One       Date:  2009-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.